- Todos > Quality and Safety: Medicines > Quality Assurance
- Todos > Quality and Safety: Medicines > Regulatory Support
- Todos > Quality and Safety: Medicines > Safety and Efficacy
- Palabras clave > access to medicines
- Palabras clave > availability, affordability, and quality of pharmaceutical products
- Palabras clave > medicines regulation
- Palabras clave > National Medicines Regulatory Authority (NMRA)
- Palabras clave > pharmaceutical country profile
- Palabras clave > quality assurance - medicines
- Palabras clave > regulatory systems
- Palabras clave > safety and efficacy
- Palabras clave > South-East Asia Regulatory Network (SEARN)
- Palabras clave > universal health coverage (UHC)
(2017; 87 pages)
Universal health coverage and the Sustainable Development Goal (SDG) for health will be achieved in the South-East Asia Region only if there is significant improvement in access to medicines. This paper provides information about the current trends in access to medicines in the Region and identifies five practical areas where Member States and WHO can work together to improve the availability of medicines.
These are: collaboration in procurement; cooperation in regulation; developing greater capacity to work within intellectual property rules; more rational use of antibiotics through improved antimicrobial stewardship; and improved monitoring of trends in access to medicines.